Center of Excellence
for Real World
Evidence Generation
Center of Excellence
for Real World
Evidence Generation
J-ARC, a Centre of Excellence for Real World Evidence (RWE) generation, is a joint initiative of Actu-Real, Inc. and Jehangir Clinical Development Centre (JCDC). The joint venture will focus on collecting and analyzing real world data (RWD) generated from clinical practice to support evidence-based clinical, economic and regulatory decisions.
J-ARC’s experience across the continuum of clinical development and post-approval research, along with its global delivery model, places it in a unique position to design, conduct and analyse real-world studies.
Why J-ARC ?
When looking for solutions to challenges of study design, data, analysis and conduct, J-ARC is your preferred partner of choice, because we provide “hands-on” leadership in the development and execution of projects using a creative problem-solving approach with a proven track record of success.
- Expertise that is cross – functional and spans across the pre- and post-launch continuum
- All-encompassing solution – HERCULE™ – a modular real world data analytics platform, and services, all in a global delivery model
- Innovative solutions for patient recruitment, retention, analysis, site agreements
- Pragmatic and fit-for-purpose solution ensuring tangible and quality business outcomes
- Partnering approach and metrics-driven ownership of deliverables for strategic, long-term client relationships
- Teams specially trained to conduct studies in traditional and innovative real world study designs
Why J-arc ?
When looking for solutions to challenges of study design, data, analysis and conduct, J-ARC is your preferred partner of choice, because we provide “hands-on” leadership in the development and execution of projects using a creative problem-solving approach with a proven track record of success.
- Expertise that is cross – functional and spans across the pre- and post-launch continuum
- All-encompassing solution – HERCULE™ – a modular real world data analytics platform, and services, all in a global delivery model
- Innovative solutions for patient recruitment, retention, analysis, site agreements
- Pragmatic and fit-for-purpose solution ensuring tangible and quality business outcomes
- Partnering approach and metrics-driven ownership of deliverables for strategic, long-term client relationships
- Teams specially trained to conduct studies in traditional and innovative real world study designs
Challenges We Address
Access to quality data along with consistent standards for data management and data integration
Compliance with regulatory and ethical requirements such as data privacy and data security
Combining medical, clinical and statistical expertise and judgment to derive robust and meaningful insights
The J-ARC Advantage
Rich Cross Functional Experience across the Continuum
Global mindset, Local adaptation
Customized services as per Sponsor’s needs
Strong Technology Focus
Talk to an expert
Latest News & Blogs
MHRA acknowledges that evidence from randomized trials using RWD is not generally considered of more or less value for regulatory decision making than evidence from conventional RCTs provided the data quality is robust and the trial is well-designed .
Typically, manufacturers start to seriously think about how to set an asking price for a new treatment (drug or biologic or combination) around the time of the submission of their P3 registration data. At that point they have little real evidence of the benefits and risks of the new
The concept of risk sharing is fundamental to all insurance products and contracts. At the simplest level, it is about sharing of risk between an insurance company and a policy holder for life insurance, car insurance etc. The concept is also fundamental